PATENT CLAIM ANALYSIS

Application Number: 15885046
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "482000"]

Abstract:
The present invention is generally directed to an oral pharmaceutical tablet composition comprising a sulfate salt, for example, sodium sulfate, wherein the composition is capable of administration by direct oral ingestion and by disintegration in water prior to oral ingestion. The present invention is further directed to use of such oral pharmaceutical tablet formulations to induce laxation or to treat or prevent constipation.

Claim (Index 5):
The oral solid pharmaceutical composition of  claim 4 , wherein the composition comprises at least about 60% by weight of sodium sulfate and potassium sulfate.

Metadata:
- Claim Count in Document: 95.0
- Percentile: 86.0
- Lexical Diversity: 1.54545
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12531150', '14295646', '15387317', '12336463', '14294660']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7026655276215785
- 35 USC 102 Novelty (BERT): 0.5237879070461445
- Combined Prediction Score: 0.6847777655640351
- Mean Citation Score: 221.929536
- Max Citation Score: 225.00584
- Similarity Product: 117.01394938239098

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test